ArticleJournal of managed care & specialty pharmacy2022

Bleeding in patients with hemophilia who have inhibitors: Modeling US medical system utilization and cost avoidance between recombinant factor VIIa products with different clinical dosing requirements.

W Allan Alexander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.